Datasets included in the final model
|
1 |
ALL |
Acute lymphoblastic leukemia |
26 |
441 |
2,104 |
2 |
BLCA |
Bladder Urothelial Carcinoma |
19 |
240 |
484 |
3 |
BRCA |
Breast invasive carcinoma |
51 |
372 |
1,103 |
4 |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
14 |
219 |
406 |
5 |
COAD_READ |
Colon adenocarcinoma and Rectum adenocarcinoma |
51 |
478 |
5,582 |
6 |
DLBC |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
35 |
325 |
933 |
7 |
ESCA |
Esophageal carcinoma |
35 |
334 |
880 |
8 |
GBM |
Glioblastoma multiforme |
36 |
247 |
533 |
9 |
HNSC |
Head and Neck squamous cell carcinoma |
42 |
299 |
729 |
10 |
KIRC |
Kidney renal clear cell carcinoma |
32 |
233 |
490 |
11 |
LAML |
Acute Myeloid Leukemia |
28 |
326 |
816 |
12 |
LCML |
Chronic Myelogenous Leukemia |
10 |
214 |
346 |
13 |
LGG |
Brain Lower Grade Glioma |
17 |
176 |
285 |
14 |
LIHC |
Liver hepatocellular carcinoma |
17 |
181 |
315 |
15 |
LUAD |
Lung adenocarcinoma |
63 |
389 |
1,689 |
16 |
LUSC |
Lung squamous cell carcinoma |
15 |
188 |
324 |
17 |
MESO |
Mesothelioma |
21 |
170 |
286 |
18 |
MM |
Multiple Myeloma |
18 |
205 |
351 |
19 |
NB |
Neuroblastoma |
32 |
267 |
512 |
20 |
OV |
Ovarian serous cystadenocarcinoma |
34 |
336 |
917 |
21 |
PAAD |
Pancreatic adenocarcinoma |
30 |
230 |
448 |
22 |
SCLC |
Small Cell Lung Cancer |
66 |
405 |
1,598 |
23 |
SKCM |
Skin Cutaneous Melanoma |
55 |
391 |
1,610 |
24 |
STAD |
Stomach adenocarcinoma |
24 |
336 |
910 |
25 |
THCA |
Thyroid carcinoma |
16 |
201 |
310 |
Subtotal |
787 |
567 |
28,328 |
Datasets excluded from the final model
|
1 |
ACC |
Adrenocortical carcinoma |
1 |
20 |
20 |
2 |
CLL |
Chronic Lymphocytic Leukemia |
3 |
29 |
33 |
3 |
MB |
Medulloblastoma |
4 |
47 |
52 |
4 |
PRAD |
Prostate adenocarcinoma |
6 |
259 |
454 |
5 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
9 |
377 |
1,168 |